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Introduction
Arterial Hypertension (AH) is a chronic disease that requires 
treatment for life. Their control is directly related to the degree 
of patient adherence to therapy that is indicated to him [1,2]. 
Failure to medication adherence is associated not only to the 
act of taking the prescribed medicines, but also in the way the 
patient leads the treatment indacations [3].
To identify, evaluate and measure patient adherence to the 
prescribed treatment, several direct and indirect methods have 
been developed and used [2]. Direct methods are characterized 
as the dosage of the active substance/drug metabolite and 
indirect methods include strategies as questionnaires and 
interviews, among others [2,4].
The objective of this review is to identify assessment methods 
and therapy adherence scales in hypertensive patients.
Methodology
The present Mini Review consists of a literature review, 
based on search of articles in Web of Science and PubMed 
Search engines, in which the following keywords were 
used: Arterial hypertension; Hypertensive patients; Therapy 
adherence; Adherence assessment methods; Adherence Scales. 
Additionally, in order to increase the search results, were also 
included in this review websites of official entities linked to 
health. The period defined for the search of articles was from 
1986 to 2015, in Portuguese or English language. The inclusion 
criteria used were scientific articles and reports that were 
considered potentially to study aim. After screening by reading 
the abstracts and full articles, to evaluate if they corresponded 
to the objective under study, were included a total of 22 articles 
and reports. This review was carried out from from February to 
May 2015.
Results
The World Health Organization estimates that 30% to 40% of 
the world population suffers from hypertension. Portugal is no 
exception to this reality [5], because there are about two million 
hypertensives [6]. This organization has defined high blood 
pressure as "a disease characterized by a chronic elevation of 
systolic blood pressure (SBP) and/or diastolic blood pressure 
(DBP)” [7]. Drug treatment and non-pharmacological help to 
maintain the blood pressure (BP) below 140 mmHg for SBP and 
90 mmHg for DBP [8]. 
Being chronic can be controlled, but never cured. Therefore, it 
requires lifelong treatment. The stability of its values is directly 
related to the degree of patient adherence to therapy that is 
indicated to him [2]. 
Failure to medication adherence is associated not only to the 
act of taking the prescribed medicine, but in the way the patient 
leads the treatment [3], being influenced by several factors such 
as age, socioeconomic status, level of education, knowledge of 
the disease, the cost of medicine, the timing of doses, dietary 
restrictions, leisure and work, among others [2].
To measure and evaluate patient adherence to prescribed 
treatment, various direct and indirect methods have been 
developed and used [1].
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Direct Methods
They seek to verify that the medicine has indeed been ingested 
[9,10]. There are two distinct ways to obtain such evidence [9].
Biological analysis
It consists of blood test or urine/feces to detect ingested drug or 
its metabolites [9]. It is objective but there may be variations in 
the metabolism of the drug which also alters the concentrations 
of the drug / metabolites [10].
Adding an indicator to ingested medication
It is the addition of an innocuous substance to the body such as 
B complex) [9]. It is an expensive evaluation [10].
Indirect Methods
These methods include simple strategies and, when used in 
a standardized manner, can give valuable information on the 
degree of adherence to treatment and therefore are useful in 
clinical practice [11]. 
The main indirect methods require the patient's cooperation.
Patient diary
The patient is oriented to register, daily, all events related to 
the use of medicines [12] and if the book is filled properly, it 
could provide important information [9] (time and amount used 
of each medicine, difficulties encountered, external situations 
that interfered the time to take the medicines, adverse reactions 
and other) [12] can be correlated with non-adherence [9]. The 
disadvantage of this method is that the registers can be easily 
changed by the patient.
Structured questionnaires or interviews
Also known as psychometric measures of treatment adherence 
[13], they are methodological tools that assess user behavior 
beyond the empirical management data obtained by simple 
observation of everyday conduct [4]. These have been the type 
of indirect methods most commonly used [4,14], especially over 
the last decade [4]. It is a fast, simple and inexpensive method 
but the results can be distorted by the patient and depending on 
the questionnaire it can be just feasible in practice because of 
its length [10].
In this category, we highlight the questionnaires Morisky-Green 
(TMG) [15], Haynes and Sacket, Brief Medication Questionnaire 
(BMQ) Questionnaire of Adherence to Medications - Team 
Qualiaids (QAM-Q), Hill-Bone compliance scale, Measure 
adherence to treatment (MAT) as well as questionnaires of food 
adhesion and adherence to physical activity.
The method of Haynes and Sacket is based on a question to the 
patient, whose affirmative response classifies it as non-adherent 
[4,11].
The BMQ questionnaire is an instrument divided into three areas 
that identify barriers to adherence as the regime (covering the 
difficulties the patient to name the medication and doses used, in 
addition to the reporting of missing days and / or doses), beliefs 
(the presence or not of drugs that do not work well, or cause any 
adverse reaction) and memory in relation to medical treatment 
in the patient's perspective (refers to the presence of a scheme 
of multiple daily doses and the account of the difficulties the 
patient to take the medication) [1,14], and a score greater than or 
equal to one, in any of these indicates positive potential for non-
adherence to treatment, and the total score of the questionnaire, 
in which no positive response indicates adherence to treatment, 
a positive response suggests the likely accession treatment, 
two answers and three or more positive indicate, respectively, 
likely poor adherence and low adherence to treatment [16]. In 
the original study, the domain had a sensitivity of 80% and 
specificity of 100% [1]. 
The QAM-Q is a tool designed to address the act (if the individual 
takes and when he takes medicines), the process (as he takes 
the medicine in a seven-day period, changes doses, taking the 
wrong way, or if he pauses) and the result of joining (if the 
pressure is controlled) [4], which makes this questionnaire has 
three questions from which you can build three non-accession 
measures: 1) Proportion of dosages taken - continuous measure 
of the act to adherence, 2) process of taking pills - ordinal 
measure of the process of adherence, 3) outcome - dichotomous 
outcome measure to adhere [1,4]. In the presence of one of these 
conditions the respondent is considered non-adherent [4], it is 
only considered adherent an individual who reports having taken 
80% to 120% of the prescribed dose correctly [17]. The original 
study had a sensitivity of 62.5% and specificity of 85.7% [1]. 
The scale of Hill-Bone assesses user behavior on three important 
behavioral domains to treat high BP: 1) reducing sodium intake, 
2) number of visits and 3) taking the medication. This scale 
consists of 14 items in three subscales [18].
TMG it is a measure built in 1986 and constitutes the most 
widely used instrument to measure compliance with the use 
of medications [4]. The fundamental theory of the measure 
states that the inappropriate use of drugs occurs in one or all 
of the following forms: forgetfulness, carelessness and stop the 
medication when feeling better or worse [1]. It is easy to measure, 
date, with a relatively small number of questions understandable 
that provide verification of the user's attitude towards taking 
medicines. It is a qualitative instrument and the questions are 
timeless [4]. The original version had low sensitivity, 43,6% and 
reasonable specificity, 81,4% and consists of four questions: 1) 
Do you ever forget to take your medicine? 2) Do you sometimes 
neglect to take your medicine? 3) When you feel better, you 
sometimes stop taking your medicine? 4) Sometimes if you feel 
worse when taking the medication, you stop taking it? [14]. 
The affirmative answer to any of these questions classifies the 
individual as non-adherent [11].
In studies conducted subsequently to its creation, the TMG 
is not efficient to relate controlled BP levels and positive 
attitude towards taking the medicinal product [1]. This lack 
of correlation with clinical outcomes Morisky motivated to 
expand this questionnaire, adding four more questions to the 
originals. Each of the eight items of Morisky Medication 
Adherence Scale (MMAS-8) measures the specific behavior of 
taking medicine, identifying aspects that contribute or not for 
adherence [11]. This new questionnaire is more reliable [1] and 
sensitivity compared to the one with four items. The degree of 
adhesion was determined in accordance with the resulting score 
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of the sum of all correct answers: high adherence (eight points), 
average adherence (six to <eight points) and poor adherence 
(<six points) [19]. 
The MAT contains the following questions: 1) Have you ever 
forgotten to take medication? 2) Have you ever been careless 
with the hours of taking medication for your disease? 3) Have 
you ever stopped taking medications for your disease, on your 
own initiative, because it was better? 4) Have you ever stopped 
taking medications for your illness on your own initiative, for 
having felt worse? 5) Have you ever taken one or more tablets 
for your disease on your own initiative, after having felt worse? 
6) Have you ever interrupted the treatment for your illness for 
letting your medicines end? 7) Have you ever stopped taking 
medication for your illness for some other reason other than the 
indication of the doctor? [3]. Items 1, 2, 3 and 4 were adapted 
Morisky [13]. 
Some researchers were concerned to evaluate the psychometric 
characteristics of questionnaires that propose to measure the 
level of physical activity [20] and food accession [11]. 
Within the various types of questionnaires to assess the 
level of physical activity, the International Physical Activity 
Questionnaire (IPAQ) [14], is the instrument that has been 
most widely used [11], containing reasonable measurement 
properties for monitoring levels of physical activity [20]. This 
comprises four presentations, two in the long form and two in 
short form [11], containing data from physical activity habits 
of moderate to vigorous intensity within different areas of life 
(work, household chores, transportation and leisure) [20] thus 
classifying individuals as sedentary or active [14].
Once inside the methods of assessment of food accession, the 
instruments available in the literature [11], stands out the Food 
Frequency Questionnaire Sodium (QFASó), which evaluates 
the consumption of foods with high sodium content, in order 
to quantify the sodium intake intrinsically present in food. It 
consists by fifteen foods, and the frequency of consumption of 
each is reported by the patient. Other interviews used also assess 
behaviors related to salt intake (adding no more than 4g of salt 
in meals, avoid adding salt in food already prepared, as well 
as use of the salt shaker at the table, avoid the consumption of 
foods with high sodium levels) [21].
To answer the issues, present in these questionnaires / interviews 
researchers propose two types of scales, dichotomous and the 
Likert [4,13,19].
The origin of the dichotomous scale ("Yes = 0" or "no = 1") 
in relation to other forms of self-report, reside mainly in the 
construction of the questions in the negative, where the answer 
"No" means adherence [13], this fact allows to avoid the bias 
of positive responses [19]. The adherence level results from the 
simple addition of each item values [13], and only classifies the 
patient in adherent or non-adherent.
The Likert scale can vary in different possible answers ranging 
from never to always, considering that zero corresponds to 
never and the highest value, such as six matches ever [4]. The 
membership level is obtained by adding the values of each item 
and dividing by the number of items [13].
In both scales, higher values mean higher levels of adherence 
[13,19].
In order to analyze the data with a larger sample and test the 
sensitivity of the Likert scale to capture adherence patterns, we 
proceeded to the conversion of the Likert scale for dichotomous, 
which is known as "converted dichotomous scale". The 
conversion was made according to the following criteria: the 
Likert scale came to no. (1) of dichotomous scale, rarely (2) and 
(3) sometimes, often (4), almost often (5) and always (6), the 
Likert scale began to yes (0), the dichotomous scale [13]. Upon 
completion of the sum of the points and dividing by the total 
number of issues, it becomes a converted dichotomous scale 
this time to adherents and non-adherents [3].
In studies, there was an equal internal consistency for the Likert 
scale and when it is converted into dichotomous. Rather, the 
dichotomy scale has a low internal consistency. But within the 
Likert scale internal consistency also varies depending on the 
number of items, for studies with four items had lower internal 
consistency to the ones with seven items [13].
As for the standard deviation is more dispersing in the results in 
dichotomous scale than the Likert scale, especially the converted 
dichotomous scale, which has a very broad standard deviation, 
which favors starting its sensitivity to capture variations in 
treatment adherence [13].
Registration of pharmaceuticals exemption in pharmacy
It is being increasingly used and runs through computerized 
systems [1], as is the case in many Sifarma 2000 Portuguese 
community pharmacies [22]. In this method, the adhesion can 
be measured by the availability of medicine for multiple time 
intervals, the measuring intervals of multiple gaps in therapy, 
or for medicine possession rate [1]. This kind of method is 
associated with the medication electronic monitoring and the 
pills count [3,11].
Medication Electronic Monitoring (MEMS)
The most modern Method, expensive but accrued by Oigman 
[9], Mira and Filipa [10] requires the use of special flasks, 
containing a microprocessor in the cover, and it is based on the 
fact that each opening and closing of the cover to be stored as 
a dose [1,9]. The data collected later by a computer, inform the 
dates, times and the intervals between "probable" doses [9].
Counting pills
One of the most appropriate methods for this evaluation [9], is 
quite objective [11], quantifiable and easy to perform but does 
not provide information about interval between doses or about 
"free days without medication" [10]. It is associated often with 
other methods assessment of adherence to therapy [1]. For the 
calculation of the number of effective medicines taken during a 
certain time interval and the number of medicines prescribed, 
there is obtained the percentage of adhesion [13]. Values equal 
to or above 80% are considered compliant [9,13].
Discussion
It is considered that non-adherence is a major cause of not 
controlled high blood pressure [19]. To measure the degree of 
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adherence of hypertensive patients to therapy direct and indirect 
methods were found [1].
Direct methods are objective but are very expensive and 
biological analysis does not assess how and when the patient 
made the doses which becomes a false impression of adherence 
[10].
Indirect processes as they require the patient's cooperation, 
and although they are the most used, from the outset, see their 
validity compromised, as these can hide or change information 
relevant to the evaluation.
This is very much present in the patient diary, for example 
elderly patients usually forget and confuse many past [9] events, 
and the psychometric measures.
Nevertheless, this type of self-reported methods, in contrast to 
techniques such as quantification of drugs and / or metabolites 
in body fluids, MEMS or pill counts are simple, rapid, non-
invasive and economic [10], and can provide a look in real 
time about the adherent behavior and potential reasons for non-
adherence of the patient [19].
A likely explanation for the increased use of questionnaires 
is the interest of health professionals in understanding the 
phenomenon of adherence / non-adherence which consequently 
leads to control/ no control of the PA [4].
Among the various questionnaires found, the method of 
Haynes and Sacket is the poorest in terms of information as it is 
constituted only by a single question [11].
But the questionnaire BMQ, the QAM-Q and the Hill-Bone 
scale cover three important areas that are directly related to the 
theme. 
Initially, the use of the first scale of adherence to Morisky 
allowed to determine the adherent and non-adherent patients 
[4], as well as some of the causes [1]. With the creation of 
MMAS-8 began to be possible to measure the specific behavior 
of taking medicines, identifying aspects that are contributing or 
not to adherence [11]. But it was still not possible to evaluate 
the incorrect use of medicines [19], because it does not address 
issues such as time and method of use.
The MAT is composed of seven questions [3] in which the 
first four are adapted of Morisky. The other three items came 
uncover situations of non-compliance because they relate to 
situations that were not covered by the adherence of four items 
[13].
Overall, the approaches to adherence to antihypertensive 
treatment bring little emphasis on compliance verification 
instrument to dietary recommendations and physical activity 
[11]. Throughout this research there was a great difficulty in 
finding questionnaires to assess these two parameters that is 
to assess non-adherence. Just a self-report method was found, 
the scale of Hill-Bone, which relates to adhesion to medication 
and the consumption of sodium [18]. As described above, the 
non-compliance is not just the act of ingesting the medicine so 
there is the need for better evaluation of adherence, to create /
crowd the various questionnaires, so that all the criteria can be 
evaluated.
Within the various types of scale that measure the level of 
compliance, the dichotomous only classifies the patient in 
adherent and non-adherent [13], as the other two mentioned 
have a higher sensitivity to rate the level of compliance, because 
a person can be adherent but not 100%.
The dispensing medication at the pharmacy registry method is not 
completely effective, since the patient can get their medication 
at another pharmacy and thus the calculations for the medicine 
possession rate or range of gaps in therapy are not true.
The collected data of the MEMS may indicate an overestimated 
adherence if the opening of the weak does not reflect the 
ingestion by the patient [9].
In pill counts even if the subjects had good adherence to 
treatment that does not mean he made use of the pills, as he may 
have removed the pills from blister / bottle without, however, 
ingest them and even that he has ingested them he may not have 
taken them in the right does and times [1].
In short, evaluation methods of adherence to therapy currently 
available only provide an estimate of the current behavior of 
patient compliance [12].
Conclusion
With this literature review, it is concluded that currently there is 
a method for evaluating adherence considered "gold standard" 
[1]. Although there are different tools that can be used to 
measure treatment adherence, direct and indirect methods, and 
some of them have a high sensitivity and specificity none has 
the ability to measure the level of adherence to therapeutic as 
a whole. It is necessary to evaluate the presence of factors that 
difficult the blood pressure control, such as excessive sodium 
intake, physical exercise and not taking medication or take it 
incorrectly [19]. It is therefore necessary that the search for the 
ideal method must be continued.
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